Blood pressure drugs cut heart events 11% only at 80% adherence, Oxford trial data presented at ESC 2026 show, even as trial patients slipped.
A WEHI-led Science study found gut cells in quiet IBD stay set to die, a RIPK1-independent program that tracks later flares.
LUX-ZEPLIN logged one 248 keV recoil at 2.6 sigma. The same 220 live days already ruled out ordinary WIMPs, and earlier xenon excesses have faded.
Georgia, Tennessee and Texas joined an 11,458-case cyclospora outbreak tied to Taylor Farms lettuce, even as product tests stayed negative.
Generation Lab is pitching 1 Generation, a weekly shot of two unnamed generics, as youth blood in a vial, while owning neither drug and racing a...
NASA’s Roman Space Telescope is cruising to L2 after an Aug. 30 Falcon Heavy launch, set to pour public survey data into a dark energy fight.
An Oxford natural experiment links Shingrix to a 9% lower heart burden than Zostavax, and the authors put the effect on the AS01 adjuvant more than...